Affinity Asset Advisors’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $339K | Sell |
518,025
-142,564
| -22% | -$93.4K | 0.05% | 68 |
|
|
2025
Q1 | $404K | Sell |
660,589
-354,751
| -35% | -$217K | 0.04% | 69 |
|
|
2024
Q4 | $1.07M | Sell |
1,015,340
-305,813
| -23% | -$321K | 0.14% | 63 |
|
|
2024
Q3 | $2.59M | Sell |
1,321,153
-297,987
| -18% | -$584K | 0.35% | 53 |
|
|
2024
Q2 | $3.25M | Buy |
1,619,140
+1,290,323
| +392% | +$2.59M | 0.37% | 51 |
|
|
2024
Q1 | $454K | Hold |
328,817
| – | – | 0.06% | 73 |
|
|
2023
Q4 | $372K | Hold |
328,817
| – | – | 0.07% | 69 |
|
|
2023
Q3 | $497K | Buy |
328,817
+61,243
| +23% | +$92.5K | 0.14% | 62 |
|
|
2023
Q2 | $428K | Buy |
+267,574
| New | +$428K | 0.15% | 60 |
|
|
2023
Q1 | – | Sell |
-883,654
| Closed | -$584K | – | 67 |
|
|
2022
Q4 | $584K | Hold |
883,654
| – | – | 0.23% | 47 |
|
|
2022
Q3 | $981K | Hold |
883,654
| – | – | 0.27% | 37 |
|
|
2022
Q2 | $1.87M | Buy |
883,654
+106,044
| +14% | +$225K | 0.79% | 22 |
|
|
2022
Q1 | $1.69M | Buy |
+777,610
| New | +$1.69M | 0.27% | 34 |
|